#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic cutaneous lupus erythematosus VEXAS syndrome Mantle cell lymphoma stage IV Head and neck cancer Gaucher's disease type I NTRK gene fusion overexpression Choroidal dystrophy Duchenne muscular dystrophy Malformation venous Oesophageal carcinoma Prophylaxis against transplant rejection Gastroenteropancreatic neuroendocrine tumour disease Ornithine transcarbamoylase deficiency Mucopolysaccharidosis II Mantle cell lymphoma refractory More trials…

    Learn about Rare Diseases

    Usher’s syndrome – Life with Disease Marfan’s syndrome Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information Chondrosarcoma metastatic – Basic Information Medulloblastoma – Basic Information Hairy cell leukaemia recurrent – Trials in Disease Mucopolysaccharidosis III – Diagnostics Leiomyosarcoma recurrent – Life with Disease Toxic epidermal necrolysis – Life with Disease Arterial tortuosity syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cariprazine Zidesamtinib Dostarlimab Ide397 Interferon Beta-1B Vb10.16 Flutamide Zongertinib Bendamustine Hydrochloride Dinutuximab Beta Cebsulfase Alfa Ck-0045 GRISNILIMAB SETARITOX Nesolicaftor Hydroxychloroquine Sulfate Alternaria Alternata (402) Linperlisib Bisoprolol Fumarate Florbetapir (18F) Tetrahydrouridine More therapies…

    Learn about Your Condition

    Inner ear disorder Infertility female Wheezing Dysmenorrhoea Leiomyosarcoma Stress urinary incontinence Hepatic cancer Non-Hodgkin's lymphoma Osteogenesis imperfecta Cutaneous calcification Hypereosinophilic syndrome Circulatory collapse Cervix carcinoma stage I Lennox-Gastaut syndrome Hyponatraemia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Study on Ropivacaine for Managing Post-Operative Pain in Patients Undergoing Lumbar Arthrodesis Surgery

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Ropivacaine Hydrochloride
    Spain

  • Study of Aficamten for Children with Symptomatic Obstructive Hypertrophic Cardiomyopathy

    Recruiting

    4 1
    Investigated Diseases:
    • Hypertrophic cardiomyopathy
    Investigated Drugs:
    • Aficamten
    Ireland Italy Spain

  • Study of cobimetinib and atezolizumab combination therapy in children and adults with advanced or metastatic soft tissue sarcoma

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Soft tissue sarcoma
    Investigated Drugs:
    • Atezolizumab
    • Cobimetinib
    France

  • Title: Study of tianeptine effectiveness in treating cognitive symptoms (brain fog) in patients who have recovered from COVID-19

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Post-acute COVID-19 syndrome
    Investigated Drugs:
    • Tianeptine Sodium
    Poland

  • Study on Ivosidenib and Azacitidine for Adults with Myelodysplastic Syndromes and IDH1 Mutation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Myelodysplastic syndrome
    Investigated Drugs:
    • Ivosidenib
    • Azacitidine
    France Germany Italy The Netherlands Spain

  • Study of Nipocalimab or IVIG for Pregnant Women at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Human Normal Immunoglobulin (Iv)
    • Nipocalimab
    • Prednisone
    Austria Belgium Germany Hungary The Netherlands Poland
Previous Page
1 … 306 307 308 309 310 … 1,649
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!